Marex Group PLC

MRX is in a Stage 2 advance within a long-term uptrend with rising EMAs and moving averages. Medium-term bias remains bullish, but the short-term pullback into the rising 50-day SMA and flat-to-declining short-term EMAs calls for deferred execution. Waiting for price to hold and reclaim the support zone near the 50-day SMA offers a higher-probability entry point.

• ↑Q1 2026 revenue $692 M (+48% YoY) & EPS $1.52 (+55% YoY)
• ↑Winterflood and Hamilton Court deals drove significant revenue contributions
• ↓High leverage elevates debt risk during market downturns